Pharma Mirror
MAY 1, 2024
Addiction is affecting a large portion of people’s lives at the minute, but one of the things people often struggle with is knowing how to afford rehab. There’s a common misconception that it costs thousands upon thousands of pounds and is entirely unattainable for people in some circles of society. However, that’s precisely what it is, a misconception, and many options can help people, no matter how wealthy or poor they are.
Pharmaceutical Technology
MAY 1, 2024
AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect remains unknown.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 1, 2024
Sales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first quarter. The company aims to extend its patent exclusivity.
Pharmaceutical Technology
MAY 1, 2024
Eli Lilly has announced that its net income rose to $2.24bn in Q1 2024, a 67% increase from $1.34bn in the same period of 2023.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MAY 1, 2024
Sales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals that surpassed analyst expectations, though the company warned momentum could slow in the months ahead.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 1, 2024
Scientists have developed a vaccine against a notorious drug-resistant superbug, targeting molecules on its surface that are also found on other bacteria and fungi.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 1, 2024
Novartis and Japanese biopharmaceutical company PeptiDream have expanded their partnership for the discovery of peptides.
Bio Pharma Dive
MAY 1, 2024
The partnership follows Astellas’ investment in the biotech last year and adds to its portfolio of donor-derived cellular medicines.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 1, 2024
India is now putting in place a mechanism to combat malaria as drug resistance poses a serious challenge. The treatment of malaria depends on timely diagnosis and efficient medication, especially artemisinin-based combination therapies (ACTs) that help in getting rid of parasites and relieve symptoms.
Pharmaceutical Technology
MAY 1, 2024
‘Janssen’ will no longer be seen on drug labels following the Johnson & Johnson brand name adoption.
Rethinking Clinical Trials
MAY 1, 2024
Dr. Gregory Tasian In this Friday’s PCT Grand Rounds, Gregory Tasian of the Children’s Hospital of Philadelphia will present “Comparative Effectiveness of Kidney Stone Surgery in Pediatric Patients: The PKIDS Trial.” The Grand Rounds session will be held on Friday, May 3, 2024, at 1:00 pm eastern. The Pediatric Kidney Stone (PKIDS) Care Improvement Network Trial is a patient-centered, pragmatic clinical trial comparing the effectiveness of stone clearance for 3 surgical m
Pharmaceutical Technology
MAY 1, 2024
Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases (CVDs).
Fierce Pharma
MAY 1, 2024
Just about two months into his CEO job at Emergent BioSolutions, Joseph Papa has laid out his turnaround plan for the CDMO-turned-biopharma company. | Merely about two months into his CEO job at Emergent BioSolutions, Joseph Papa has laid out his turnaround plan for the CDMO-turned-biopharma company. And it involves a major organizational restructuring.
Pharmaceutical Technology
MAY 1, 2024
Enlaza has raised $100m in a Series A funding round led by the Life Sciences group of JP Morgan Asset Management’s private capital unit.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
MAY 1, 2024
The progressive neurological condition affects more than six million people worldwide
Pharmaceutical Technology
MAY 1, 2024
The sprinkle formulation of Ingrezza is approved as an alternative for Huntington’s patients who have difficulty swallowing.
pharmaphorum
MAY 1, 2024
Discover how digital tools can provide insights to help us. Digital technology could be a game-changer that offers the elusive promise of tackling the root cause, not just the conditions themselves, when it comes to human health.
Pharmaceutical Technology
MAY 1, 2024
Antibody drug conjugates (ADCs) are a rapidly growing therapeutic class that leading data and analytics company GlobalData forecasts will generate more than $45bn in revenue by 2030.
Fierce Pharma
MAY 1, 2024
It’s no secret that U.S. biopharma companies rely on Chinese contractors to provide lab research and drug manufacturing services. | Facing a push for China-U.S. decoupling from Washington, the industry trade group BIO now wants to quantify the U.S.’s dependence on Chinese CDMOs through a survey.
Pharmaceutical Technology
MAY 1, 2024
In this issue: Following the RSV therapy and vaccine rollout, understanding molecular glues, using pharmacovigilance for active drug discovery, and more.
Pharma Times
MAY 1, 2024
Bladder cancer, including papillary tumours, is the ninth most common cancer type worldwide
Pharmaceutical Technology
MAY 1, 2024
The US-based company is working alongside the University of Texas MD Anderson Cancer Center to fund the Phase I/II clinical trial.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Fierce Pharma
MAY 1, 2024
Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. | Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. The company plans to sell products such as its COVID treatment Paxlovid and a migraine nasal spray in this way, it told the Financial Times.
Pharmaceutical Technology
MAY 1, 2024
Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However, they serve distinct purposes and come with different considerations for clinical trial sponsors and contract research organisations (CROs). Understanding these differences is vital for selecting the right technology and provider to meet your trial needs.
pharmaphorum
MAY 1, 2024
Explore the challenges in weight loss treatments despite the billions spent on clinical trials for weight loss drugs. Discover why capacity remains a critical issue in the industry.
Pharmaceutical Technology
MAY 1, 2024
Last week, Roche released promising first-quarter (Q1) 2024 sales figures for VABYSMO, a vascular endothelial growth factor (VEGF) and angiopoietin-2 inhibitor for wet age-related macular degeneration (wAMD), diabetic macular oedema (DME), and macular oedema following retinal vein occlusion.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
MAY 1, 2024
FTC sends more warnings to pharma companies over 'junk' patents to protect drugs from generic competition, including Novo Nordisk's Ozempic.
Pharmaceutical Technology
MAY 1, 2024
Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However, they serve distinct purposes and come with different considerations for clinical trial sponsors and contract research organisations (CROs). Understanding these differences is vital for selecting the right technology and provider to meet your trial needs.
pharmaphorum
MAY 1, 2024
Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.
Fierce Pharma
MAY 1, 2024
Even with the threat of a potential new competitor in the respiratory syncytial virus (RSV) vaccine race on the horizon, GSK and its leading Arexvy shot aren’t sweating. | The company's respiratory syncytial virus vaccine Arexvy takes some two-thirds of the RSV market share, GSK reported. Next up is a key FDA decision on the vaccine's use in the 50-to-59 age group, which would add another 50 million U.S. adults to its reach.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
130 
Let's personalize your content